Li Wei, Pan Jianying, Li Jintao, Guo Jinshan, Zeng Chun, Xie Denghui
Department of orthopedic Surgery, Center for Orthop aedic Surgery, The Third Afiliated Hospital of Southern Medical University, China.
Department of Histology and Embryology, School of Basic Medical Science, Southern Medical University, Guangzhou, China.
J Orthop. 2021 Feb 20;24:173-181. doi: 10.1016/j.jor.2021.02.027. eCollection 2021 Mar-Apr.
In patients with partial meniscus defect, the implantation of polyurethane meniscal scaffold has become a common method for the treatment of meniscus vascular entry and tissue regeneration. However, it is unclear whether polyurethane meniscal scaffold will yield better clinical and MRI results after surgery. This meta-analysis compared the clinical and MRI results of polyurethane meniscal scaffold in some patients with meniscus defects.
By searching PubMed, Embase, and Cochrane Library, a systematic review of studies evaluating the clinical outcomes of patients with polyurethane meniscal scaffold implantation. The search terms used are: "meniscus", "meniscal", "scaffold", "Actifit" "polyurethane" and "implant". The study was evaluated based on the patient's reported outcome score, accompanying surgery, and radiology results. Genovese scale was used to evaluate morphology and signal intensity, and Yulish score was used to evaluate the imaging performance of articular cartilage.
There were 16 studies that met the inclusion criteria, a total of 613 patients, and the overall average follow-up time was 41 months. The clinical scores at the final follow-up, such as VAS, IKDC, Tegner, and KOOS, were significantly improved compared with preoperatively. The MS, SI, and IIRMC scores evaluated in MRI showed no significant difference between preoperative and final follow-up. However, for AC (OR 0.34, 95% CI 0.11-1.00; P = 0.05) and AME (OR 0.08, 95% CI 0.03-0.22; P < 0.01), the final follow-up results were worse than preoperatively.
This meta-analysis found that compared with preoperative, the clinical effect of the final follow-up was significantly improved. However, MS, SI, and IIRMC in MRI parameters did not change significantly. In addition, the final follow-up results of AC and AME showed a deteriorating trend. Therefore, for patients with partial meniscus defects, polyurethane meniscal scaffold seem to be a viable option, and further research is needed to determine whether the deterioration of AC and AME is clinically relevant.
在半月板部分缺损患者中,植入聚氨酯半月板支架已成为治疗半月板血管长入和组织再生的常用方法。然而,目前尚不清楚聚氨酯半月板支架术后是否能产生更好的临床和磁共振成像(MRI)结果。本荟萃分析比较了聚氨酯半月板支架在部分半月板缺损患者中的临床和MRI结果。
通过检索PubMed、Embase和Cochrane图书馆,系统回顾评估聚氨酯半月板支架植入患者临床结局的研究。使用的检索词为:“半月板”“半月板的”“支架”“Actifit”“聚氨酯”和“植入物”。根据患者报告的结局评分、伴随手术情况和放射学结果对研究进行评估。采用Genovese量表评估形态和信号强度,采用Yulish评分评估关节软骨的成像表现。
有16项研究符合纳入标准,共613例患者,总体平均随访时间为41个月。末次随访时的临床评分,如视觉模拟评分(VAS)、国际膝关节文献委员会(IKDC)评分、Tegner评分和膝关节损伤和骨关节炎疗效评分(KOOS),与术前相比均有显著改善。MRI评估的半月板评分(MS)、信号强度(SI)和改良国际半月板研究学会(IIRMC)评分在术前和末次随访之间无显著差异。然而,对于关节软骨(AC,比值比[OR]0.34,95%可信区间[CI]0.11 - 1.00;P = 0.05)和半月板外区域(AME,OR 0.08,95%CI 0.03 - 0.22;P < 0.01),末次随访结果比术前更差。
本荟萃分析发现,与术前相比,末次随访时的临床效果有显著改善。然而,MRI参数中的MS、SI和IIRMC没有显著变化。此外,AC和AME的末次随访结果呈恶化趋势。因此,对于半月板部分缺损患者,聚氨酯半月板支架似乎是一个可行的选择,需要进一步研究以确定AC和AME的恶化在临床上是否相关。